Refine by
Type 1 Diabetes To Type 2 Diabetes Suppliers & Manufacturers
22 companies found
based inMontreal, QUEBEC (CANADA)
As a specialty therapeutics, clinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of diabetic kidney disease, type 1 and type 2 diabetes, ...
Inversago Pharma Inc. is focused on the development of peripherally-acting CB1 receptor (CB1) inverse agonists for the treatment of diabetic nephropathy, NASH, type 1 diabetes and Prader-Willi Syndrome. While previous generation of centrally-acting ...
based inLake Bluff, ILLINOIS (USA)
Realize Therapeutics is focused on providing Health Care Practitioners (HCPs) with medical nutrition solutions for their patients suffering from obesity and type 2 diabetes. Realize’s strategy is to develop microbe and endocannabinoid formulations ...
based inBagsværd, DENMARK
We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. ...
based inMadison, WISCONSIN (USA)
Privately-owned company operating in Madison, Wisconsin (MG&E Innovation Center) and Chicago, Illinois. Team of experts in the field of stem cell research which allows RMS to make unprecedented scientific breakthroughs. Extensive experience in stem ...
We are developing autologous and allogeneic versions of ILC cellular therapeutic. In the case of autologous ILC cellular therapeutic we will convert the diabetes patients own cells into iPSC cells followed by differentiation of the patient derived ...
based inMalvern, PENNSYLVANIA (USA)
LifeScan is a global leader in blood glucose monitoring innovation and digital health technology and has a vision to create a world without limits for people with diabetes and related conditions. More than 20 million people and their caregivers ...
based inLexington, MASSACHUSETTS (USA)
Fractyl Health is an organ editing metabolic therapeutics company focused on pioneering a new approach to the treatment of Type 2 Diabetes (T2D). Our goal is to transform T2D treatment from chronic blood glucose management to disease-modifying ...
Our lead product candidate, the Revita DMR System, or Revita®, is a first-in-class procedural therapy designed to target the duodenum as a root cause of type 2 diabetes. For people with advanced type 2 diabetes, the main form of therapy to ...
based inConcord, MASSACHUSETTS (USA)
Beta Bionics is proud to be incorporated as a Massachusetts public benefit corporation and certified as a B Corporation. We believe we were one of the first, if not the first medical device company to be doing business as a benefit corporation, and ...
based inTualatin, OREGON (USA)
Genteel is the world’s only lancing device that uses vacuum and depth control to draw blood from anywhere on the body. This innovative, pain-free technology allows users with diabetes to check blood sugar anywhere on the body, giving sore fingertips ...
The Genteel Lancing Device allows those with diabetes to check their blood sugar without pain, using vacuum and depth control. Each Genteel comes with 6 contact tips, 2 nozzles, and a travel and organizer pouch. Compatible with most square shaft ...
based inLondon, UNITED KINGDOM
Multiomic Health Limited is a next-generation precision medicine business, applying computational systems biology to develop and commercialize data assets for metabolic syndrome. Multiomic is a next-generation precision medicine business, applying ...
based inBoston, MASSACHUSETTS (USA)
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — ...
based inBlankenfelde-Mahlow, GERMANY
Medipan GmbH was founded in 1992 and is an independent, family company. The company started with the marketing of radioimmunoassays for the characterization of thyroid function, disease and tumor markers, with its partners from nuclear medicine ...
Radio ligand assay for the quantitative determination of autoantibodies to Insulin (IAA) in human ...
based inSanta Ana, CALIFORNIA (USA)
Aqua Medical has developed a disruptive, vapor-based, endoscopic, ablation technology designed to treat gastrointestinal disease and prevent GI cancers. Aqua Medical’s unique ablation technology consists of high-temperature water vapor created by a ...
based inAmsterdam, NETHERLANDS
Caelus Health is an Amsterdam-based biotech company with in-depth knowledge of the microbiome, dedicated to the development and commercialization of microbiota-based products to prevent and treat cardiometabolic disorders, including Diabetes, and ...
Intestinimonas: as basis of a drug to treat Type 2 Diabetes has been tested in animal trials; a first clinical Proof of Concept study will start in ...
based inBoston, MASSACHUSETTS (USA)
Since GI Dynamics’ founding in 2003, our mission has been to alleviate the symptoms of type 2 diabetes and obesity for patients fighting these global epidemics worldwide. Our revolutionary EndoBarrier is a testament to the GI Dynamics mission. The ...
EndoBarrier is an endoscopically delivered medical device intended to help restore healthy blood sugar levels and reduce weight. EndoBarrier is an investigational medical device for people living with uncontrolled type 2 diabetes and obesity that ...
based inNew York, NEW YORK (USA)
Oramed Pharmaceuticals (NASDAQ: ORMP) has developed an innovative technology to transform injectable treatments into oral therapies. Oramed’s flagship product, an oral insulin capsule, has the potential to better the lives of millions of diabetics ...
Diabetes is a chronic condition characterized by hyperglycemia, or elevated blood glucose levels. If left untreated, diabetes may lead to complications such as cardiovascular disease, chronic renal failure, retinopathy and ...
based inToronto, ONTARIO (CANADA)
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in people with diabetes. This pre-clinical technology is directed at regulating a hormone in the pancreas called somatostatin which in Type ...
based inGunpo-si, SOUTH KOREA
DxGen is Point-Of-Care (POC) diagnostics company. We provide products for entire stages of diabetes care from initial assessment to post-diagnosis treatment. Our goal is to help make clinical decisions in the care and treatment of patients at the ...
Test Kit is for in-vitro diagnostic (IVD) use to determine Glycated Albumin (GA) and Albumin quantitatively from serum or plasma. It is useful at initial assessment, the onset of therapy, and post-therapeutic monitoring of glycemic control. ...
based inVancouver, BRITISH COLUMBIA (CANADA)
The Diabits app is a personalized diabetes management tool made by Bio Conscious for people with type I and type II diabetes. Using a machine learning algorithm, the Diabits app builds a personalized model of your blood sugar. Continuous glucose ...
See your future glucose values and manage your fluctuations with ease. Diabits Calculates future glucose using a Machine Learning Algorithm designed to learn your unique ...
based inBeachwood, OHIO (USA)
We develop cell therapies - at a dramatically increased speed, at lower cost, and with less R&D risk. Trailhead Biosystems merges developmental biology and cell therapeutics with cutting-edge hardware and computerized experimental design and ...
based inHergiswil, SWITZERLAND
BioLingus is a Swiss biotech company spearheading the development of oral (sublingual) delivery of peptides and proteins for chronic diseases and immuno-therapy via our innovative formulation technology. Our company focuses on the development of ...
Due to the fact that BioLingus drug administration is sublingual, and the use of a specific carrier molecule in the BioLingus formulation, the BioLingus technology is particularly effective for sublingual immuno ...